Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | SVP & CFO | September 29, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date September 29, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 168,993 |
Reported balance
After 2026-09-29 transaction · row 1
1 source rowRow 1 · 2026-09-29 · Sale · Disposed 2,850 · Balance 168,993 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
F2: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2022 Filed Mar 29, 2022 00:48 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 33,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003393 · form4-03282022_050357.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,208 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| March 23, 2022 Filed Mar 26, 2022 00:53 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 4,167 | $27.03 | $112,634.01 |
DisclosureSEC source: 0001415889-22-003381 · form4-03252022_050310.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,333 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,617 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 21:25 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 3,042 | $31.86 | $96,918.12 |
DisclosureSEC source: 0001415889-21-001979 · form4-04132021_020408.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,941 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 00:19 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 612 | $33.69 | $20,618.28 |
DisclosureSEC source: 0001415889-21-001945 · form4-04072021_050433.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,542 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 00:56 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 508 | $36.14 | $18,359.12 |
DisclosureSEC source: 0001415889-21-001723 · form4-03312021_050317.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,154 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,657 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 29, 2021 Filed Apr 1, 2021 00:56 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 953 | $32.68 | $31,144.04 |
DisclosureSEC source: 0001415889-21-001723 · form4-03312021_050317.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,662 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:44 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 54,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001660 · form4-03252021_010324.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,615 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 23, 2021. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 20:32 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 39,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-046394 · tm2015775d3_form4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,145 F1 · kind: The restricted stock vests in four equal annual installments on the first, second, third and fourth anniversaries of April 10, 2020. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 21:53 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 612 | $43.22 | $26,450.64 |
DisclosureSEC source: 0001104659-20-044727 · tm2015378d1_4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,378 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, which was previously reported. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 01:39 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 507 | $40.74 | $20,655.18 |
DisclosureSEC source: 0001104659-20-041409 · tm2014433-2_4.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,990 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,656 shares of restricted stock, which was previously reported. Read SEC document |
| March 28, 2020 Filed Apr 1, 2020 01:39 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 953 | $37.76 | $35,985.28 |
DisclosureSEC source: 0001104659-20-041409 · tm2014433-2_4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,497 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,112 shares of restricted stock, which was previously reported. Read SEC document |
| April 06, 2019 Filed Apr 9, 2019 20:42 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 612 | $70.50 | $43,146.00 |
DisclosureSEC source: 0001144204-19-018899 · tv518452_form4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,450 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, which was previously reported. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 20:42 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 507 | $70.54 | $35,763.78 |
DisclosureSEC source: 0001144204-19-017759 · tv517842_4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,062 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,656 shares of restricted stock, which was previously reported. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 15,064 | $0.00 Strike: $66.39 | $0.00 |
DisclosureSEC source: 0001144204-19-017409 · tv517659_4.xml · derivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,064 Underlying: Common Stock · 15,064 shares Expires 2029-03-27 F1 · security: The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019. F1 · derivative.exercise_date: The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 12,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-017409 · tv517659_4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,569 F1 · security: The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 21:25 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 9,600 | $0.00 Strike: $57.06 | $0.00 |
DisclosureSEC source: 0001144204-18-019987 · tv490743_4.xml · derivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Common Stock · 9,600 shares Expires 2028-04-05 F1 · security: The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 21:25 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-019987 · tv490743_4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,118 F1 · security: The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 21:17 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 507 | $58.22 | $29,517.54 |
DisclosureSEC source: 0001144204-18-019002 · tv490181_form4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,118 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 13,250 | $0.00 Strike: $49.51 | $0.00 |
DisclosureSEC source: 0001144204-17-018953 · v463545_form4.xml · derivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,250 Underlying: Common Stock · 13,250 shares Expires 2027-03-30 F1 · security: The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 6,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-018953 · v463545_form4.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,625 F1 · security: The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.